Which company was first to receive a patent for CRISPR gene-editing technology in eukaryotic cells, sparking a famous intellectual property battle in scientific history?

CRISPR gene-editing technology represents one of the most significant scientific product breakthroughs of the 21st century. This revolutionary tool has transformed genetic research, medicine, and biotechnology with its ability to edit DNA precisely. While its applications continue to expand into agriculture, disease treatment, and beyond, how well do you know the corporate history behind this world-changing innovation?

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Broad Institute (MIT/Harvard)
CRISPR Therapeutics (founded by Emmanuelle Charpentier)
University of California, Berkeley (Jennifer Doudna's team)
Editas Medicine (founded by Feng Zhang)